EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Changes in Food Waste among a Sample of U.S. Consumers after Beginning Anti-Obesity Medication

Jamil Mansouri, Brian E Roe iD

Nutrients · 2024

DOI: 10.3390/nu16193274 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Jamil Mansouri und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Agricultural Economics, Purdue University, West Lafayette, IN 47907, USA. Hauptthemen laut MEDLINE: Anti-Obesity Agents, Obesity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ohio State University, Ohio State University’s Van Buren fund, USDA-NIFA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Glucagon-like peptide-1 agonists (GLP1As) are increasingly prescribed to treat obesity. While studies document how these medications impact dietary habits, their relationship to consumer food waste is unexplored. Approximately one-third of all food is wasted, which creates substantial economic and environmental damage. The purpose of this study is to assess how consumers alter food waste after beginning GLP1As and to identify factors associated with this relationship.

Methods

Retrospectively reported changes in the amount of food wasted since beginning a GLP1A are gathered from a sample of 505 U.S. consumers via a self-administered online survey. Regression analysis yields associations between changes in post-GLP1A-uptake food waste and the length and type of medication use, medication side effects, post-uptake changes in dietary habits, and respondent characteristics.

Results

A total of 25% of respondents agree they waste more food since beginning the medication, while 61% disagree. Respondents are significantly less likely to agree with this statement if they have been on the medication a longer time and are significantly more likely to agree if they reported experiencing nausea since beginning the medication. Dietary changes consistent with more vegetable intake are also significantly associated with less waste.

Conclusions

Uptake of a novel class of anti-obesity medications may significantly affect food waste patterns. With the potential for widespread adoption of such medications, and given the societal import of reducing food waste, understanding the interaction of these two consumer trends is critical for projecting their joint impact on the food system and for equipping new GLP1A users to limit food waste.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Obesity AgentsObesityHumansFemaleMaleUnited StatesAdultMiddle AgedRetrospective StudiesFeeding BehaviorGlucagon-Like Peptide 1Consumer BehaviorYoung AdultSurveys and QuestionnairesAgedFoodAdolescentFood Loss and Waste

Stichwörter der Autor:innen

U.S. consumersanti-obesity medicationsfood wasteglucagon-like peptide-1 agonistsurvey

Substanzen

Anti-Obesity AgentsGlucagon-Like Peptide 1Food Loss and Waste

Autor:innen und Institutionen

  • Department of Agricultural Economics, Purdue University, West Lafayette, IN 47907, USA.
  • Department of Agricultural, Environmental and Development Economics, Ohio State University, Columbus, OH 43210, USA.

ORCID-Profile: Brian E Roe

Förderung

  • Ohio State University
  • Ohio State University’s Van Buren fund
  • USDA-NIFA

Zitieren

APA

Mansouri, J., & Roe, B. E. (2024). Changes in Food Waste among a Sample of U.S. Consumers after Beginning Anti-Obesity Medication. Nutrients. https://doi.org/10.3390/nu16193274

Vancouver

Mansouri J, Roe BE. Changes in Food Waste among a Sample of U.S. Consumers after Beginning Anti-Obesity Medication. Nutrients. 2024. doi:10.3390/nu16193274

BibTeX
@article{Mansouri2024,
  author = {Mansouri, Jamil and Roe, Brian E},
  title = {Changes in Food Waste among a Sample of U.S. Consumers after Beginning Anti-Obesity Medication},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16193274}
}
Kostenlos starten →